| Oneup Care Llc | |
|
1010 1st St N Ste 220 Alabaster AL 35007-8623 | |
| (205) 620-8606 | |
| Not Available |
| Full Name | Oneup Care Llc |
|---|---|
| Speciality | Internal Medicine |
| Location | 1010 1st St N Ste 220, Alabaster, Alabama |
| Authorized Official Name and Position | Andrey Samal (OWNER) |
| Authorized Official Contact | 2055316179 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Oneup Care Llc 4565 Magnolia Dr Birmingham AL 35242-5358 Ph: (205) 531-6179 | Oneup Care Llc 1010 1st St N Ste 220 Alabaster AL 35007-8623 Ph: (205) 620-8606 |
| NPI Number | 1265209829 |
|---|---|
| Provider Enumeration Date | 12/05/2023 |
| Last Update Date | 01/05/2024 |
| Medicare PECOS PAC ID | 0648613430 |
|---|---|
| Medicare Enrollment ID | O20240208002559 |
News Archive
Nanostart-holding MagForce AG, a leading medical technology company focusing on nanomedicine in oncology, announced today the treatment of a recurrent glioblastoma patient with the company's NanoTherm therapy.
Coventry, the creator of the secondary market for life insurance in the U.S., applauds the New York Court of Appeals decision in Kramer v. Phoenix Life Insurance Company as a significant victory for life insurance consumers and the secondary market for life insurance.
The risk of serious adverse effects on the blood status and bone marrow of patients during chemotherapy can be predicted by a model developed at Linköping University, Sweden.
The UN's criteria for individual rights and fairness form the basis for a newly-published critique of COVID-19 contact-tracing app guidelines for Europe, and of apps already being used by millions in Austria and Singapore.
Many patients showing signs of dementia are quickly diagnosed with Alzheimer's disease when they might actually suffer from frontotemporal dementia, delaying the appropriate treatment for them.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265209829 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (* (Not Available)) | Primary |
| 208M00000X | Hospitalist | (* (Not Available)) | Secondary |
| Provider Name | Andrey A Samal |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1134482847 PECOS PAC ID: 8729389408 Enrollment ID: I20160930002168 |
News Archive
Nanostart-holding MagForce AG, a leading medical technology company focusing on nanomedicine in oncology, announced today the treatment of a recurrent glioblastoma patient with the company's NanoTherm therapy.
Coventry, the creator of the secondary market for life insurance in the U.S., applauds the New York Court of Appeals decision in Kramer v. Phoenix Life Insurance Company as a significant victory for life insurance consumers and the secondary market for life insurance.
The risk of serious adverse effects on the blood status and bone marrow of patients during chemotherapy can be predicted by a model developed at Linköping University, Sweden.
The UN's criteria for individual rights and fairness form the basis for a newly-published critique of COVID-19 contact-tracing app guidelines for Europe, and of apps already being used by millions in Austria and Singapore.
Many patients showing signs of dementia are quickly diagnosed with Alzheimer's disease when they might actually suffer from frontotemporal dementia, delaying the appropriate treatment for them.
› Verified 4 days ago
News Archive
Nanostart-holding MagForce AG, a leading medical technology company focusing on nanomedicine in oncology, announced today the treatment of a recurrent glioblastoma patient with the company's NanoTherm therapy.
Coventry, the creator of the secondary market for life insurance in the U.S., applauds the New York Court of Appeals decision in Kramer v. Phoenix Life Insurance Company as a significant victory for life insurance consumers and the secondary market for life insurance.
The risk of serious adverse effects on the blood status and bone marrow of patients during chemotherapy can be predicted by a model developed at Linköping University, Sweden.
The UN's criteria for individual rights and fairness form the basis for a newly-published critique of COVID-19 contact-tracing app guidelines for Europe, and of apps already being used by millions in Austria and Singapore.
Many patients showing signs of dementia are quickly diagnosed with Alzheimer's disease when they might actually suffer from frontotemporal dementia, delaying the appropriate treatment for them.
› Verified 4 days ago
Alabama Family Medicine, P.c. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 300 1st St N, Suite C, Alabaster, AL 35007 Phone: 205-663-5990 Fax: 205-663-5440 | |
Carol M Johnson Md Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 224 1st St N, Suite 200, Alabaster, AL 35007 Phone: 205-664-7570 Fax: 205-664-7584 | |
E Simmons Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1010 1st St N, Alabaster, AL 35007 Phone: 205-620-8606 Fax: 205-620-8681 | |
Pulmonary Medicine Associates Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1022 1st St N Ste 501, Alabaster, AL 35007 Phone: 205-620-0359 Fax: 205-620-9686 | |
Bhc-cahaba Internal Medicine Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1004 1st St N, Suite 300, Alabaster, AL 35007 Phone: 205-664-7970 Fax: 205-664-1890 | |
Gilmer Urgent Care Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 100 Gilbert Dr, Alabaster, AL 35007 Phone: 205-259-3991 Fax: 205-383-1574 |